TMEM119
Transmembrane protein 119
Also known as: OBIF, TM119_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q4V9L6
- Gene
- TMEM119
- Ensembl
- ENSG00000183160
- Chromosome
- 12
- Canonical length
- 283 aa
- Protein class
- Predicted membrane proteins, Predicted secreted proteins, Transporters
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
Involved in positive regulation of bone mineralization; positive regulation of osteoblast differentiation; and positive regulation of osteoblast proliferation. Located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
283 residues, UniProt reviewed canonical sequence.
>Q4V9L6|TMEM119
1 MVSAAAPSLL ILLLLLLGSV PATDARSVPL KATFLEDVAG SGEAEGSSAS SPSLPPPWTP
61 ALSPTSMGPQ PITLGGPSPP TNFLDGIVDF FRQYVMLIAV VGSLAFLLMF IVCAAVITRQ
121 KQKASAYYPS SFPKKKYVDQ SDRAGGPRAF SEVPDRAPDS RPEEALDSSR QLQADILAAT
181 QNLKSPTRAA LGGGDGARMV EGRGAEEEEK GSQEGDQEVQ GHGVPVETPE AQEEPCSGVL
241 EGAVVAGEGQ GELEGSLLLA QEAQGPVGPP ESPCACSSVH PSVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM119 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 57 nTPM
Expression across tissuesHPA
Tissue
- cervix: 57 nTPM
- lymph node: 45 nTPM
- lung: 36 nTPM
- gallbladder: 34 nTPM
- urinary bladder: 30 nTPM
- adipose tissue: 29 nTPM
Single-cell type
- microglia: 58 nCPM
- fibroblasts: 31 nCPM
- pericytes: 29 nCPM
- peritubular myoid cells: 28 nCPM
- neutrophils: 15 nCPM
- hepatic stellate cells: 13 nCPM
Immune cell
- neutrophil: 1.4 nTPM
- basophil: 1.2 nTPM
- memory CD4 T-cell: 0.4 nTPM
- naive B-cell: 0.4 nTPM
- non-classical monocyte: 0.4 nTPM
- naive CD4 T-cell: 0.3 nTPM
Brain region
- white matter: 53 nTPM
- medulla oblongata: 42 nTPM
- thalamus: 40 nTPM
- pons: 36 nTPM
- spinal cord: 35 nTPM
- midbrain: 31 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.95
- gnomAD pLI
- 0.63
- gnomAD missense Z
- 0.29
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- biomineral tissue development
- BMP signaling pathway
- endochondral ossification
- negative regulation of bone resorption
- negative regulation of myotube differentiation
- osteoblast differentiation
- positive regulation of bone development
- positive regulation of bone mineralization
- positive regulation of gene expression
- positive regulation of osteoblast differentiation
- positive regulation of osteoblast proliferation
- spermatid differentiation
- spermatogenesis
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Transmembrane protein 119
- TMEM119 family
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TMEM119 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM119 as an antibody target. Whether an autoantibody or antibody against TMEM119 could matter depends on whether native TMEM119 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM119 is annotated at the cell surface, where native TMEM119 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TMEM119 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...